Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price20.32 USD
Fair value14.98
Ethical score70.0/100
Our investment reviews on this name
2026-07-03Read Markup14.62+39.0% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
SailPoint, Inc. holds its Markup at $20.32. Consolidating, no directional conviction, held for 33 days.
As held on the ledger · 2026-09-21
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 33 days
Price at the screen
$20.32
Valuation
N/A trailing · 50.45 forward price to earnings
Values screen
PASS· score 70.0
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
0.24%
Below 33%
Interest-bearing debt is just 0.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
9.12%
Below 49%
Money owed to the company is 9.1% of assets, under the 49% limit.
Pass
Revenue purity
1.01%
Below 5%
Only 1.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 26.3% above the base estimate.
Third-party analyst targets: 25 covering, consensus Buy. The average target sits +8% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Digital identity guard priced past its profits
Picture a company selling the keys to every corporate door, yet still losing money on each one sold. SailPoint sells identity security tools that let firms control who gets in and what they can touch across regions. The business grows revenue at 22 percent, clears the ethical screen, and draws buy ratings from two dozen analysts with a median target near 19 dollars. Yet at 15.68 the shares sit above our fair value of 14.12, and none of that growth has turned into profit.
Forward earnings sit at 39 times while margins run at minus 14 percent and return on equity is minus 2 percent. Those figures show a firm still investing heavily without clear returns. The unknown moat leaves open the question of whether rivals can copy the offering faster than SailPoint can widen its lead.
High multiples on negative earnings often signal peak optimism rather than durable advantage. Currency swings and slower enterprise spending could widen the gap between price and value further. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SAIL trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-09Markup$20.45+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (24 analysts) rates it buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-08Markup$20.45+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (24 analysts) rates it buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-06Markup$20.45+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (24 analysts) rates it buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-05Markup$20.45+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (24 analysts) rates it buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-04Markup$20.45+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (24 analysts) rates it buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-03Markup$20.45+0.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (24 analysts) rates it buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-02Markup$20.45+26.5%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 26.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (24 analysts) rates it buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-12Markup$16.17+10.6%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (24 analysts) rates it buy, with a mean price target of $18.
2026-07-18Markup$14.62+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (24 analysts) rates it buy, with a mean price target of $18.
2026-07-03Markup$14.62+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
